V. Ratziu Et Al. , "Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.," Hepatology (Baltimore, Md.) , 2024
Ratziu, V. Et Al. 2024. Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.. Hepatology (Baltimore, Md.) .
Ratziu, V., Yilmaz, Y., Lazas, D., Friedman, S. L., Lackner, C., Behling, C., ... Cummings, O. W.(2024). Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.. Hepatology (Baltimore, Md.) .
Ratziu, Vlad Et Al. "Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.," Hepatology (Baltimore, Md.) , 2024
Ratziu, Vlad Et Al. "Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.." Hepatology (Baltimore, Md.) , 2024
Ratziu, V. Et Al. (2024) . "Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.." Hepatology (Baltimore, Md.) .
@article{article, author={Vlad Ratziu Et Al. }, title={Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.}, journal={Hepatology (Baltimore, Md.)}, year=2024}